Abbott’s CardioMEMS™ HF System is the leading remote monitoring platform for both HFpEF1 and HFrEF patients clinically proven to:
As telemedicine becomes more common, the CardioMEMS HF System is a safe, reliable way to help your patients manage their heart failure.
The CardioMEMS HF System offers you real-time notification of patient changes and simple, convenient access to secure data for proactive, personalized patient management. It also provides patients with a heightened awareness of the factors affecting their health and a powerful sense of control.
The CardioMEMS HF System remotely monitors changes in pulmonary artery (PA) pressure, an early indicator of the onset of worsening heart failure. These early changes can often be addressed through simple adjustments to care, such as titration of medications, most often without requiring an appointment with the patient.
Traditionally, clinicians have focused on physiological markers (patient weight, blood pressure, etc.) to detect worsening heart failure. Unfortunately, these markers appear late in the time course of decompensation. Relying on them leaves little time to respond before hospitalization is necessary.
The CardioMEMS HF System is proven through clinical trial data to reduce heart failure hospitalizations and mortality,2,3 as well as improve QOL for HFrEF and HFpEF patients.3,4,5 The presymptomatic data provided by the CardioMEMS HF System allow for proactive changes in medical therapy before heart failure symptoms appear.1 The ability to individually set patient thresholds allows physicians to personalize and optimize care and medical management for each patient.